Surprisingly, these exosomes effectively inhibited tumor recurrence and metastasis by upregulating programmed death-ligand 1 (PD-L1) expression in tumors, reducing the immune escape of tumor cells when combined with ICB53. Here, CD274 is linked to neoplasm.